REACH compliance management

Under the REACH Regulation, the industry has a responsibility to identify and manage the risks associated with the chemicals they manufacture and market in the EU. 


Manufacturers and importers of substances in quantities of 1 tonne or more per year need to gather information on substance properties and uses, make an assessment of hazards and potential risks and submit a registration dossier to the European Chemicals Agency (ECHA) demonstrating that any risks are adequately controlled.  Failure to register within the required timescales means that the substance will no longer be allowed to be manufactured or imported until compliance is achieved.

From May 2018, phase-in substances manufactured or imported in the EU in quantities of 1-100 tonnes or more per year must be registered.  REACH places a significant burden on industry and presents numerous challenges, particularly to small and medium-sized enterprises (SMEs) that may not have the resources available to meet registration requirements.

We can help you achieve REACH compliance and ensure the continued success of your products by providing tailored and cost-effective support and advice. 

Our range of services includes:

  • Scoping of regulatory obligations under REACH;
  • Substance identification and characterisation;
  • Preparation of an Inquiry Dossier to enable data sharing;
  • Collation and review of existing information on substance properties and identification of data gaps;
  • Preparation of a registration dossier in IUCLID and pre-submission screening;
  • Development of testing proposals;
  • Preparation of a Chemical Safety Report using CHESAR;
  • Establishing Derived No Effect Levels (DNELs) and Risk Characterisation Ratios (RCRs) for human exposures;
  • Identification of exposure scenarios and exposure assessment based on existing data and modelling with additional measurements;
  • Support for gathering information on uses from downstream users;
  • Provision of guidance and training on REACH processes and related topics.
We're here to provide you with more information and answer any questions you may have. Contact us
  • IOMworld Posted: yesterday
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/C2daujZVK7
  • IOMworld Posted: 2 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/JC30t6iKhf
  • IOMworld Posted: 3 days ago
    Talking about the physical and emotional aspects of working from home & how it impacts both organisations & humans… https://t.co/OYw7dsIvHF
  • IOMworld Posted: 4 days ago
    There is a legal duty for landlords to assess &control the risk of exposure to legionella bacteria in both domestic… https://t.co/RP4nHi3atu
  • IOMworld Posted: 7 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/HkPOPVzUgh
  • IOMworld Posted: 7 days ago
    Announcement: IOM's Online Face Fit Tester Training Live Workshop has been rescheduled to 1st June 10am. Join us on… https://t.co/8vfocIsDh3
  • IOMworld Posted: 7 days ago
    Join the IOM in this great opportunity to be a part of ground-breaking research on developing innovative methods fo… https://t.co/ri97lwycAP
  • IOMworld Posted: 9 days ago
    IOM talks about the physical and emotional aspects of working from home and how it impacts both organisations and h… https://t.co/cowqG7mN7M
  • IOMworld Posted: 15 days ago
    Health risks from Coronavirus and occupational disease are big issues for businesses. Our clients are benefiting fr… https://t.co/SwEyyQONfU
  • IOMworld Posted: 16 days ago
    Find out about the importance of Respirator Protection Equipment (RPE) in the workplace, join our online Face Fit T… https://t.co/AnEEVH0sVq